Aminoglycoside-Modifying Enzymes Are Sufficient to Make <i>Pseudomonas aeruginosa</i> Clinically Resistant to Key Antibiotics
Aminoglycosides are widely used to treat infections of <i>Pseudomonas aeruginosa</i>. Genes encoding aminoglycoside-modifying enzymes (AMEs), acquired by horizontal gene transfer, are commonly associated with aminoglycoside resistance, but their effects have not been quantified. The aim...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-07-01
|
| Series: | Antibiotics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-6382/11/7/884 |